Universitätsklinikum Carl Gustav Carus Dresden

Limited Effect of Anti-PD-1 in advanced Skin Tumors of Patients with hemato-oncological Primary Disease: A retrospective multi-center Study of ADO (2019) Leiter-Stoeppke U, Loquai C, Meier F, Rafei-Shamsabadi D, Hassel J, Glutsch V, Sirokay J, et al. Conference contribution Association of an initial Exanthem with Vemurafenib and Cobimetinib for a better Therapeutic Success in metastatic Melanoma Patients (2019) Kaehler K, Bohne AS, Gutzmer R, Satzger I, Meier F, Reinhardt L, Zimmer L, et al. Conference contribution Large amplicon droplet digital PCR for DNA-based monitoring of pediatric chronic myeloid leukaemia (2019) Krumbholz M, Görlitz K, Albert C, Lawlor J, Suttorp M, Metzler M Journal article Impact of social support on psychosocial symptoms and quality of life in cancer patients: results of a multilevel model approach from a longitudinal multicenter study (2019) Sauer C, Weis J, Faller H, Junne F, Honig K, Bergelt C, Hornemann B, et al. Journal article c-Met and PD-L1 on Circulating Exosomes as Diagnostic and Prognostic Markers for Pancreatic Cancer (2019) Lux A, Kahlert C, Grützmann R, Pilarsky C Journal article Clinical relevance of comprehensive genomic analysis in patients with advanced-stage neuroendocrine neoplasms: Results from the MASTER trial of the German Cancer Consortium (2019) Kreutzfeldt S, Apostolidis L, Oles M, Horak P, Heilig CE, Heining C, Hutter B, et al. Conference contribution Second allogeneic stem cell transplantation in acute lymphoblastic leukemia patients in second complete remission or relapse: A study on behalf of the ALWP / EBMT (2019) Nagler A, Labopin M, Finke J, Brecht A, Schanz U, Niittyvuopio R, Neubauer A, et al. Conference contribution Randomized phase 2 trial of chemoradiotherapy plus induction or consolidation chemotherapy as total neoadjuvant therapy for locally advanced rectal cancer: CAO/ARO/AIO-12 (2019) Hofheinz R, Fokas E, Allgaeuer M, Polat B, Klautke G, Grabenbauer G, Fietkau R, et al. Conference contribution Efficacy of Budesonide Orodispersible Tablets as Induction Therapy for Eosinophilic Esophagitis in a Randomized Placebo-Controlled Trial (2019) Lucendo AJ, Miehlke S, Schlag C, Vieth M, von Arnim U, Molina-Infante J, Hartmann D, et al. Journal article LONG-TERM OUTCOME OF TOCILIZUMAB FOR PATIENTS WITH GIANT CELL ARTERITIS: RESULTS FROM PART 2 OF THE GIACTA TRIAL (2019) Stone JH, Bao M, Han J, Aringer M, Blockmans D, Brouwer E, Cid MC, et al. Conference contribution